Sanofi SA (SNY)
48.67
-0.15
(-0.31%)
USD |
NASDAQ |
May 17, 16:00
48.65
-0.02
(-0.04%)
Pre-Market: 20:00
Sanofi Accounts Payable (Quarterly)
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 8.100B |
| June 30, 2023 | 20.95B |
| December 31, 2022 | 7.306B |
| June 30, 2022 | 6.850B |
| December 31, 2021 | 6.997B |
| June 30, 2021 | 6.395B |
| June 30, 2020 | 5.533B |
| December 31, 2019 | 5.951B |
| June 30, 2019 | 5.778B |
| December 31, 2018 | 5.766B |
| June 30, 2018 | 5.298B |
| December 31, 2017 | 5.558B |
| December 31, 2016 | 4.543B |
| December 31, 2015 | 4.173B |
| June 30, 2015 | 4.452B |
| December 31, 2014 | 4.440B |
| June 30, 2014 | 4.404B |
| December 31, 2013 | 4.147B |
| June 30, 2013 | 4.262B |
| December 31, 2012 | 4.219B |
| June 30, 2012 | 4.078B |
| Date | Value |
|---|---|
| December 31, 2011 | 4.123B |
| June 30, 2011 | 4.504B |
| December 31, 2010 | 3.724B |
| June 30, 2010 | 3.514B |
| December 31, 2009 | 3.795B |
| June 30, 2009 | 3.836B |
| December 31, 2008 | 3.900B |
| June 30, 2008 | 4.022B |
| December 31, 2007 | 4.012B |
| June 30, 2007 | 3.693B |
| December 31, 2006 | 3.968B |
| June 30, 2006 | 3.464B |
| December 31, 2005 | 3.777B |
| June 30, 2005 | 3.467B |
| December 31, 2004 | 3.726B |
| June 30, 2004 | 930.66M |
| December 31, 2003 | 825.48M |
| June 30, 2003 | 726.94M |
| December 31, 2002 | 625.79M |
| June 30, 2002 | 631.59M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
5.533B
Minimum
Jun 2020
20.95B
Maximum
Jun 2023
8.207B
Average
6.850B
Median
Jun 2022
Accounts Payable (Quarterly) Benchmarks
| AstraZeneca PLC | 19.70B |
| Novavax Inc | 57.72M |
| Regeneron Pharmaceuticals Inc | 671.30M |
| Fulcrum Therapeutics Inc | 3.857M |
| Moderna Inc | 183.00M |